Intuitive Surgical stock is trading -8.33% below its average target price of $410.8 after dropping -1.5% during today's morning session. Analysts are giving the large-cap Medical Instruments & Supplies company an average rating of buy and target prices ranging from $322.5 to $460.0 per share.
The stock has a very low short interest at 0.9%, and a short ratio of 1.46. The company's insiders own 0.51% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 88.5% of Intuitive Surgical's shares being owned by this investor type.
Institutions Invested in Intuitive Surgical
Date Reported | Holder | Percentage | Shares | Value |
---|---|---|---|---|
2023-09-30 | Blackrock Inc. | 9% | 30,035,542 | $11,310,484,270 |
2023-09-30 | Vanguard Group Inc | 8% | 29,868,227 | $11,247,478,460 |
2023-09-30 | Price (T.Rowe) Associates Inc | 5% | 16,700,525 | $6,288,916,821 |
2023-09-30 | State Street Corporation | 4% | 14,644,433 | $5,514,654,242 |
2023-09-30 | FMR, LLC | 2% | 7,723,962 | $2,908,612,426 |
2023-09-30 | Capital World Investors | 2% | 7,558,658 | $2,846,363,898 |
2023-09-30 | Geode Capital Management, LLC | 2% | 6,773,068 | $2,550,534,266 |
2023-09-30 | Alliancebernstein L.P. | 2% | 6,766,225 | $2,547,957,397 |
2023-12-31 | Bank Of New York Mellon Corporation | 2% | 6,706,824 | $2,525,588,762 |
2023-09-30 | Morgan Stanley | 2% | 5,318,872 | $2,002,927,667 |
Besides an analyst consensus of some upside potential, other market factors point to there being mixed market sentiment on Intuitive Surgical.